FDA Nominee Heidi Overton Faces Senate Confirmation Questions
Dr. Heidi Overton fielded tough Senate questions on abortion pills, vaccine misinformation, and food safety during her FDA confirmation hearing.
Dr. Heidi Overton, President Trump's nominee to lead the Food and Drug Administration, appeared before a Senate panel for her confirmation hearing, where lawmakers pressed her on a range of contentious public health issues including abortion medication access, vaccine safety claims, and federal food oversight.
Senators questioned Overton about false statements made by President Trump regarding the measles vaccine, putting the nominee in the politically delicate position of either defending the president or affirming established scientific consensus on one of medicine's most scrutinized immunizations. The exchange underscored the tension nominees face when White House rhetoric diverges from agency science.
Read more Bessent Failed to Report JPMorgan Holdings, IG Review Finds →
Lawmakers also raised Trump's reported intervention in tobacco policy, an area traditionally governed by FDA regulatory authority. The line of questioning signaled congressional concern about whether political influence could shape the agency's independent decision-making on products affecting millions of Americans.
Abortion pills represented another flashpoint at the hearing. The FDA's approval and regulatory standing of mifepristone has remained under legal and political pressure, and senators sought to gauge whether Overton would defend the agency's existing scientific determinations or leave room for executive-branch override.
The confirmation hearing illustrated the broad portfolio the FDA chief must manage — from drug approvals and food safety enforcement to navigating an increasingly politicized public health landscape. No confirmation vote was immediately scheduled following the hearing. Continue reading at NYT > Business.
